Loading company…
Shenzhen Gatecore Biotech develops semiconductor-enabled protein detection technologies.
Founded in 2023 and based in Shenzhen, Shenzhen Gatecore Biotech develops single-molecule immunodetection platforms for research institutions, biotechnology firms, and diagnostics developers. Its systems support protein detection for disease screening, biomarker discovery, and precision diagnostics. In December 2025, it closed Series A funding from Shenzhen Capital Real Estate Fund, Shenzhen Nanshan Huirong Investment, and Taiyou Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in